Table 2 Clinical findings of cutaneous leishmaniasis, 2016–2019
Variable | Category | Percentage of cases, % (Number of cases/Total cases) |
|---|---|---|
No. of lesions | Single | 47.6 (20/42) |
Multiple | 19.1 (8/42) | |
Data not available | 33.3 (14/42) | |
Site of lesions | Face and neck | 38.1 (16/42) |
Hands | 19.0 (8/42) | |
Legs | 4.8 (2/42) | |
Trunk | 4.8 (2/42) | |
Data not available | 33.3 (14/42) | |
Interval between onset of lesion to hospital visit | < 1 month | 0 |
1–6 months | 31.0 (13/42) | |
7–12 months | 21.4 (9/42) | |
> 1 years | 9.5 (4/42) | |
Data not available | 38.1 (16/42) | |
Treatment | Miltefosine | 59.5 (25/42) |
Liposomal Amphotericin B | 7.1 (3/42) | |
Data not available | 33.3 (14/42) | |
Diagnosis | Microscopic | 83.3 (35/42) |
rK39 | 16.7 (7/42) |